Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Express Scripts
Mallinckrodt
Boehringer Ingelheim
Medtronic

Last Updated: January 26, 2022

DrugPatentWatch Database Preview

Emcure Pharms Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for EMCURE PHARMS, and what generic and branded alternatives to EMCURE PHARMS drugs are available?

EMCURE PHARMS has thirty-two approved drugs.

There are two tentative approvals on EMCURE PHARMS drugs.

Summary for Emcure Pharms
US Patents:0
Tradenames:29
Ingredients:28
NDAs:32

Drugs and US Patents for Emcure Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emcure Pharms Ltd OXYBUTYNIN CHLORIDE oxybutynin chloride TABLET;ORAL 211682-001 May 10, 2019 BX RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Emcure Pharms Ltd PROPOFOL propofol INJECTABLE;INJECTION 206408-001 Oct 12, 2021 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Emcure Pharms Ltd ACARBOSE acarbose TABLET;ORAL 202271-003 Feb 7, 2012 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Emcure Pharms Ltd LURASIDONE HYDROCHLORIDE lurasidone hydrochloride TABLET;ORAL 208058-001 Sep 4, 2019 DISCN No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Emcure Pharms Ltd LURASIDONE HYDROCHLORIDE lurasidone hydrochloride TABLET;ORAL 208058-003 Sep 4, 2019 DISCN No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
McKesson
Johnson and Johnson
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.